DOLBY LABORATORIES ($DLB) posted quarterly earnings results for Q4 2026 on Tuesday, November 17th. The company reported earnings of $1.25 per share, beating estimates of $1.21 by $0.04. The company also reported revenue of $373,540,000, missing estimates of $376,487,852 by $-2,947,852.
Stock price change since market close: -4.79%
You can see Quiver Quantitative's $DLB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DOLBY LABORATORIES Insider Trading Activity
DOLBY LABORATORIES insiders have traded $DLB stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $DLB stock by insiders over the last 6 months:
- JOHN D COULING (SVP, Entertainment) has made 0 purchases and 8 sales selling 38,334 shares for an estimated $2,213,039.
- TODD PENDLETON (SVP, Chief Marketing Officer) sold 11,876 shares for an estimated $647,857
- SHRIRAM REVANKAR (SVP, Advanced Technology Group) sold 3,000 shares for an estimated $188,130
- RYAN NICHOLSON (VP, CAO and Corp. Controller) has made 0 purchases and 2 sales selling 1,540 shares for an estimated $98,867.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
DOLBY LABORATORIES Hedge Fund Activity
We have seen 198 institutional investors add shares of DOLBY LABORATORIES stock to their portfolio, and 280 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM removed 3,637,844 shares (-98.2%) from their portfolio in Q3 2026, for an estimated $213,796,091
- MORGAN STANLEY removed 1,412,368 shares (-30.7%) from their portfolio in Q3 2026, for an estimated $83,004,867
- CAPTRUST FINANCIAL ADVISORS added 1,244,026 shares (+7414.6%) to their portfolio in Q3 2026, for an estimated $73,111,408
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. removed 808,225 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $47,499,383
- ACADIAN ASSET MANAGEMENT LLC removed 751,553 shares (-39.6%) from their portfolio in Q3 2026, for an estimated $44,168,769
- BARROW HANLEY MEWHINNEY & STRAUSS LLC added 687,911 shares (+inf%) to their portfolio in Q3 2026, for an estimated $40,428,529
- SCHRODER INVESTMENT MANAGEMENT GROUP added 617,641 shares (+inf%) to their portfolio in Q3 2026, for an estimated $36,298,761
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
DOLBY LABORATORIES Analyst Ratings
Wall Street analysts have issued reports on $DLB in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Rosenblatt issued a "Buy" rating on 11/16/2026
To track analyst ratings and price targets for DOLBY LABORATORIES, check out Quiver Quantitative's $DLB forecast page.
DOLBY LABORATORIES Price Targets
Multiple analysts have issued price targets for $DLB recently. We have seen 2 analysts offer price targets for $DLB in the last 6 months, with a median target of $85.0.
Here are some recent targets:
- Steven Frankel from Rosenblatt set a target price of $80.0 on 11/16/2026
- Patrick Sholl from Barrington Research set a target price of $90.0 on 06/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.